SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-009151
Filing Date
2020-08-04
Accepted
2020-08-04 16:24:24
Documents
77
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20200630x10q.htm   iXBRL 10-Q 1738020
2 EX-31.1 idra-20200630xex31d1.htm EX-31.1 14192
3 EX-31.2 idra-20200630xex31d2.htm EX-31.2 13902
4 EX-32.1 idra-20200630xex32d1.htm EX-32.1 7120
5 EX-32.2 idra-20200630xex32d2.htm EX-32.2 7729
6 GRAPHIC idra-20200630x10q004.jpg GRAPHIC 4421
7 GRAPHIC idra-20200630x10q011.jpg GRAPHIC 2260
8 GRAPHIC idra-20200630x10q012.jpg GRAPHIC 2312
9 GRAPHIC idra-20200630x10q013.jpg GRAPHIC 2122
10 GRAPHIC idra-20200630x10q014.jpg GRAPHIC 2434
  Complete submission text file 0001558370-20-009151.txt   7524142

Data Files

Seq Description Document Type Size
11 EX-101.SCH idra-20200630.xsd EX-101.SCH 49522
12 EX-101.CAL idra-20200630_cal.xml EX-101.CAL 45864
13 EX-101.DEF idra-20200630_def.xml EX-101.DEF 214351
14 EX-101.LAB idra-20200630_lab.xml EX-101.LAB 414944
15 EX-101.PRE idra-20200630_pre.xml EX-101.PRE 380035
16 EXTRACTED XBRL INSTANCE DOCUMENT idra-20200630x10q_htm.xml XML 1498914
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 201073647
SIC: 2836 Biological Products, (No Diagnostic Substances)